TSXV:SLHG.H - Post by User
Post by
lscfaon Apr 23, 2021 10:37am
211 Views
Post# 33054748
Research capital lowers target price
Research capital lowers target price Ma is calling for 2021 revenue of $47.1 million and fully diluted EPS of negative $0.04 per share and for 2022 revenue of $58.6 million and fully diluted EPS of $0.00. With the reiterated “Buy” rating, Ma has reduced his target price from $2.10 to $1.90, which at the time of publication represented a projected one-year return of 67 per cent.
https://www.cantechletter.com/2021/04/skylight-health-remains-a-top-pick-at-research-capital/